Officers, Directors

Consultants and Advisers

OFFICERS 

  • Frank W. Terrizzi, BA, JD – Chief Executive Officer; Chairman, Board of Directors

Mr. Terrizzi has more than 40 years of experience in the investment management industry, ranging from larger established firms to start-up organizations, three of which he helped launch and two of which he helped negotiate their merger or sale into larger entities. Frank began his career at Scudder, Stevens and Clark (Scudder) in Cincinnati where he managed individual and institutional portfolios and created a research product focused on investing in emerging entrepreneurial growth companies. At Scudder, he was selected to manage the largest separate portfolio at the firm (in excess of $600 Million for a state Public Employee’s Retirement System).​

Frank was recruited by The Central Trust Company (now PNC Bank) where he assisted, as Director of Research, in the launch of a wholly owned bank subsidiary dedicated to investment in emerging growth companies. He was also a Senior Trust officer at the bank and oversaw the management of large retirement plan portfolios for companies located in the Cincinnati area.

​In 1978, Terrizzi co-founded Renaissance Investment Management (RIM), one of the first investment advisory firms to use algorithms to determine investment policy. Besides creating the firm’s quantitatively-based and highly disciplined approach, he served as both President and Managing Director and assisted in raising more than $1.5 billion of new assets for the firm from clients in 42 states. Overseeing a staff numbering more than 50, clients of the firm included several publicly-traded companies, retirement systems, university endowments and foundations, religious organizations, union retirement plans and high net worth individuals. While at RIM, Frank created the firm’s quarterly client newsletter, appeared on both local radio and national television shows and was featured in articles in The Wall Street Journal, Institutional Investor magazine and other publications. He was sought out to serve as a guest speaker and panelist at large investment conferences in New York, Florida, California, Hawaii and Montreal, Canada and traveled extensively throughout the United States to grow RIM’s asset base. In 1995, he sold the firm to Affiliated Managers Group, a New York Stock Exchange-listed company established to acquire mid-sized investment management firms.

Frank holds a bachelor’s degree from Miami University in Oxford, Ohio and a Juris Doctor degree from The Ohio State University College of Law. He has served as an “Executive in Residence” at Miami, been a member of Miami’s Business Advisory Council and a guest lecturer on business organization and entrepreneurship. He also co-chaired a successful Capital Campaign at Miami which surpassed its fund-raising goal and was completed ahead of schedule.

In 1995, he sold the firm to Affiliated Managers Group, a New York Stock Exchange-listed company in the business of acquiring mid-sized investment management firms. Thereafter, he founded Terrizzi Investment Associates, LLC, a firm dedicated to marketing investment management services. Mr. Terrizzi holds a bachelor’s degree from Miami University in Oxford, Ohio and a Juris Doctor degree from The Ohio State University College of Law.

 

  • Marc J. Bielski, MD – Chief Medical Officer, Treasurer and Secretary, Director

Dr. Bielski possesses a strong background in the sciences and research, including emerging technologies. After graduating from New York’s University of Rochester, he participated in stem cell research in cancer immunology and immunotherapy at the M.D. Anderson Cancer Center in Houston, Texas. Following the successful completion of numerous research projects, which included several publications, he attended the University Of Texas Health Science Center School Of Medicine at San Antonio.

After moving to New York City, Dr. Bielski became a general, holistic physician working in practice with other holistic practitioners, and later in his own practice within a holistic medical clinic. His areas of expertise include gastrointestinal illnesses and various types of chronic pain. His interests in research, especially bringing cutting-edge medical technologies to market, have focused his attention towards emerging technologies rather than out-patient care. Dr. Bielski has written several articles and manuscripts. He has lectured on holistic medicine and other health-related topics, and has made guest appearances on numerous syndicated radio shows.

DIRECTORS

​​

  • Frank W. Terrizzi, BA, JD      

  • Marc J. Bielski, MD​

  • W. Brian Gibler, MD  - Director and Medical Adviser

W. Brian Gibler, MD is an emergency physician by training serving previously as Chairman of the Department of Emergency Medicine at the University of Cincinnati College of Medicine and subsequently President and CEO of the University of Cincinnati Medical Center. A clinical researcher and educator by background, he has served as the Director of the Heart ER Program of the University of Cincinnati Medical Center and Residency Program Director for the University of Cincinnati Emergency Medicine Residency Training Program. He currently is Professor of Emergency Medicine in the Department of Emergency Medicine at the University of Cincinnati College of Medicine. He is also President and founder of the Emergency Medicine Cardiac Research Group (EMCREG)-International, a multicenter trials group.

Dr. Gibler has been a leader and practicing clinician in the field of emergency medicine for more than three decades. Prior to his appointment as a Professor and Department Chairman, he was a faculty member at Vanderbilt University School of Medicine in Nashville, Tennessee and then joined the University of Cincinnati Department of Emergency Medicine in 1989 and became Residency Director in 1990. His clinical and teaching experience dates back to 1981. Dr. Gibler founded the Heart ER Program at the University of Cincinnati Hospital and served as the Director from 1991 through 1997.

Dr. Gibler is currently Co-Chairman with E. Magnus Ohman, MD, University of North Carolina-Chapel Hill for CRUSADE: Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines: The CRUSADE National Quality Improvement Initiative, with over 400 hospitals participating in the United States. He is also an Editor and Referee for numerous Emergency Medicine and Cardiology journals.

In 2008, the Board of Trustees of the Society of Chest Pain Centers bestowed upon Dr. Gibler the Raymond D Bahr Award of Excellence at the 11th Congress of Chest Pain Centers in Orlando, Florida. This award is given to individuals who demonstrate extraordinary vision, leadership, and excellence in advancing healthcare. In 1999, Dr. Gibler received the Hospital Hero Award from the Cincinnati Business Courier for his work on Chest Pain Centers. In 1995, Dr. Gibler was awarded the Outstanding Contribution to Research Award from the American College of Emergency Physicians, and Best Original Research Paper at the 3rd International Conference on Emergency Medicine in Toronto, Canada in 1990. He is also a member of the International GUSTO Trials Steering Committee and serves as a member of the National Heart Attack Alert Program Working Group. Dr. Gibler has published multiple articles on the early diagnosis and treatment of Acute Coronary Syndrome. He has contributed chapters to over 12 books and has written numerous articles, presentations, and abstracts in his field. He is the senior editor of the book, Emergency Cardiac Care, published by Mosby-Yearbook.

Dr. Gibler holds an MD from the Vanderbilt University Medical School and a Sc.B. in Biology from Brown University, where he graduated magna cum laude. He is also a graduate of the University of Cincinnati Emergency Medicine Residency Training Program where he was Chief Resident his senior year.

CONSULTANTS

  • Michael Milbocker, BS, PhD  - Chief Science Advisor; Research and Development

Michael Milbocker has broad experience in the medical device industry, embracing cardiovascular support devices, design of preclinical animal studies, design of clinical studies, and regulatory submissions. He is the founder of Praxis, LLC, co-founder of Promethean Surgical Devices, and most recently co-founder of Soft Tissue Sciences. Earlier in his career, Dr. Milbocker was Principal Scientist and Director of the Artificial Myocardium NIH sponsored IVAS program for Abiomed.

Dr. Milbocker has 25 years experience in medical device development including several SBIR research grants in cardiovascular applications and several patents in the areas of extra-cardiac actuation, tissue adhesives, in situ polymerizing tissue scaffolds for the treatment of SUI and LES, biocompatible coatings for surgical mesh, cohesive gels for dermal bulking, anti-adhesive layers for post-cardiac surgery, eye tracking devices for automated measurement of retinal blood flow, and various optical patents. Dr. Milbocker holds degrees in Physics, High Energy Particle Physics, and Theoretical Physics from Boston College and Massachusetts Institute of Technology.

ADVISERS

  • A-Medica

Michael Rosen and Allen Jones are both partners at Brussels-based A-Medica.  MyoCardioCare, Inc. has worked with A-Medica since 2014. A-Medica provides international operational support and funding for health technology & medical devices including prototyping to commercial phase; thereafter product launch and scaling revenue assistance. The company also offers business plan, regulatory, clinical, (contract) manufacturing and distribution-marketing-sales guidance.

  • Michael Rosén 

Michael Rosen has implemented large corporate financial transactions in the Nordic countries as a representative for Credit Lyonnais banking group. Michael has conducted a major restructuring while a Director of Pierrel, a listed pharmaceutical group.  As a board member for a joint-venture with Nutricia, he supervised market developments in enteral clinical nutrition; he established and managed a coordination center for Nobel Industries group’s engineering, fine chemical and pharma operations. As Director for Developmental Technologies, a contract-research venture, Rosen conducted operational restructuring with the divestment of the company.

Since 1991 Rosen has designed and executed a range of accelerated business development and venture processing projects for international markets, including pharmaceuticals, laboratory consumables, diagnostic tests and medical devices. He holds a Civilekonom degree from the Stockholm School of Economics.

  • Allen W. Jones 

Allen Jones is based in the United States and currently identifies and pursues U.S. Research & Development as well as Testing & Validation funding for A-Medica clients. In a prior responsibility, as Director of Federal Programs at DMGS, Allen identified and developed execution strategies for capturing U.S. funding for domestic and foreign based companies. He headed design and implementation of an information system throughout Europe and the US resulting in an increase in data accuracy on assets worth over $10 billion. He has also led a team that managed data collection and quality assurance for information used in the Conventional Arms Treaty talks between the then Soviet Union and NATO countries.

Throughout his career, Jones has interfaced with senior executives in the private sector, executives and officers in the federal sector, agency heads in state governments, and members of Congress and Congressional staffer. Jones was Director of a national technology transfer program working with universities and federal laboratories and has been Director of the US sponsored program for first responder technology transfer. This program identified U.S. Federal Intellectual Property with commercial potential and developed licensing agreements with industry to move associated IP into commercial sales. As Executive VP of MCCS, Inc. Allen was responsible for new market development and day to day operations for this Information Systems company. Allen began his career as a U.S. federal employee with responsibilities ranging from management of major end-items, to include budget development and justification, logistics systems design, management of a depot operations group, and fielding and trouble-shooting systems deployment in Europe and the Middle East. Allen holds a B. S. degree (Magna Cum Laude) from Indiana University in Pennsylvania.